Site Search
-
News Posted on Wed, 07/21/2021 -
News Posted on Wed, 08/18/2021 -
News Posted on Wed, 04/15/2020 -
News Posted on Fri, 05/15/2020 -
News Posted on Fri, 08/16/2019 -
News Posted on Fri, 09/14/2018 -
News Posted on Thu, 01/09/2020 -
News Posted on Thu, 01/09/2020 -
News Posted on Tue, 03/30/2021 -
News Posted on Thu, 09/03/2020 -
News Posted on Mon, 04/23/2018 -
News Posted on Thu, 04/15/2021 -
News Posted on Tue, 09/22/2020 -
News Posted on Tue, 09/10/2019 -
News Posted on Fri, 04/12/2019 -
CCR Online Magazine Article Reining in Rogue Immune Cells
A life-saving hematopoietic stem cell transplant, which replaces cancerous cells with a healthy immune system, allows many patients diagnosed with certain blood cancers to live for years with their cancer in remission. However, the treatment is not without side effects.
-
Staff Profile -
Staff Profile Xue Zhi Zhao, Ph.D.
Dr. Zhao has been a pioneer in the field of anti-AIDS agents, with a particular focus on developing inhibitors of HIV-1 integrase (IN). His recent studies have concentrated on the discovery of inhibitors that retain efficacy against virus harboring mutant forms of IN integrase, which are resistant to current FDA-approved drugs. These efforts are being done in collaboration with the NCI laboratories of Drs. Yves Pommier (Developmental Therapeutics Branch) and Stephen Hughes (HIV Drug Resistance Program).
-
News Posted on Fri, 03/23/2018 -
CCR Online Magazine Article Once Infamous, Now Beneficial
First marketed in the late 1950s, thalidomide was widely prescribed to pregnant woman as a sedative to relieve morning sickness until tragedy struck.